Deutsche Märkte geschlossen

Endo International plc (ENDP)

NasdaqGS - NasdaqGS Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
3,1200-0,1400 (-4,29%)
Ab 1:04PM EDT. Markt geöffnet.

Endo International plc

Minerva House
First Floor Simmonscourt Road Ballsbridge
Dublin 4
Ireland
353 1 268 2000
http://www.endo.com

Sektor(en)Healthcare
BrancheDrug Manufacturers—Specialty & Generic
Vollzeitmitarbeiter3.172

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Blaise ColemanPres, CEO & Director1,9MN/A1974
Mr. Terrance J. CoughlinExec. VP & COO1,95MN/A1966
Mr. Matthew Joseph MalettaExec. VP & Chief Legal Officer1,82MN/A1972
Mr. Patrick A. BarryExec. VP & Pres of Global Commercial Operations1,47MN/A1968
Mr. Mark T. BradleyExec. VP & CFON/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2019 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; VOLTAREN gel for the relief of joint pain of osteoarthritis; LIDODERM for the relief of pain; TESTOPEL, an implantable pellet indicated for TRT in conditions; EDEX to treat erectile dysfunction; and LIDODERM a topical patch product containing lidocaine. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays; and products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

Corporate Governance

Endo International plcs ISS Governance QualityScore, Stand 9. Dezember 2019, lautet 7. Die grundlegenden Scores sind Audit: 1, Vorstand: 4, Shareholderrechte: 3, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.
Mit Yahoo Nutzung stimmen Sie zu, dass Yahoo und Partner Cookies für Personalisierungs- und andere Zwecke nutzen